Polypharmacy drugs Flashcards
State the drug class, indication, relevant side effects and interactions for haloperidol
- Drug class: Anti-psychotic
- Indication:
- N&V (palliative)
- Acute delirium
- Persistent psychomotor agitation
- Schizophrenia
- Side effects:
- Drowsiness, postural hypotension, QT interval prolongation
- Extra-pyramidal- muscle rigidity, movement disorders
- Interactions:
- Drugs that prolong QT interval (amiodarone, macrolides)
State the drug class, indication, relevant side effects and interactions, including STOPP/START criteria for macrogol
- Drug class: Osmotic laxative
- Indication: Chronic constipation
- Side effects: flatulence, GI discomfort, N&V
- Interactions: Effects of warfarin may be slightly increased
- STOPP/START
- STOP: bowel obstruction (risk of perforation)
- START: opioids (prevent constipation)
State the drug class, indication, relevant side effects and interactions, including STOPP/START criteria for alendronate
- Drug class: Bisphosphonate
- Indication: Osteoporosis
- Side effects:
- Oesophagitis
- Hypophosphataemia
- Arthralgia
- GI discomfort
- Rare- osteonecrosis of jaw, atypical femoral #
- Interactions: Absorption reduced when taken with calcium salts (milk) and antacids and iron salts
- STOPP/START
- STOP: Unable to sit upright/ swallowing difficulties/ compliance issues, recent hx of upper GI bleeding
- START: maintenance corticosteroid therapy w/ previous fragility #
State the drug class, indication, relevant side effects for Strontium Ranelate
- Drug class: Anti-osteoporotic agent
- Stimulates bone formation & reduces resorption
- Indication: Severe osteoporosis with risk of fragility #
- Side effects: Arthralgia, GI discomfort, headache, insomnia, memory loss, MI, nausea, pain, paraesthesia, peripheral oedema
State the drug class, indication, relevant side effects and interactions, including STOPP/START criteria for colchicine
- Drug class: Anti-gout medication
- Indication: Acute gout, short term prophylaxis during initial therapy w/ allopurinool
- Side effects: abdo pain, diarrhoea, N&V
- Interactions: atorvastatin
- STOPP/START
- STOP: if eGFR < 10 (risk of toxicity)
For chronic treatment when no C/I to allopurinol which is first choice prophylactic in gout
- STOP: if eGFR < 10 (risk of toxicity)
State the drug class, indication, relevant side effects and interactions, including STOPP/START criteria for allopurinol
- Drug class: Xanthine oxidase inhibitor
- Indication: Prophylaxis of gout, Prophylaxis of hyperuricaemia in chemo
- Side effects: Rash (discontinue), hypersensitivity, N&V, Steven Johnson syndrome
- Interactions
- Azathioprine (toxicity)
- ACEi (hypersensitivity reactions)
- Amoxicillin (skin rash)
State the drug class, indication, relevant side effects and interactions, including STOPP/START criteria for prednisolone
- Drug class: Corticosteroid (glucocorticoid)
- Indication:
- Acute COPD exacerbation
- Asthma attack
- IBD, ITP, generalized MG, severe RA, PMR, GCA, SLE
- Side effects:
- Immunosuppression- infections
- Metabolic- DM, osteoporosis
- Mood & behavioural- insomnia, confusion, psychosis
- Mineralcorticoid- htn, hypoK, oedema
- Addisonian crisis
- Interactions:
- CYP450 inhibitors (efficacy reduced) – carbamazepine, rifampicin, phenytoin
- NSAIDs (GI bleeding risk)
- Beta agonists, theophylline, loop or thiazide diuretics (enhance hypoK)
- STOPP/START:
- STOP: if used instead of ics for maintenance in severe COPD, as long term monotherapy for RA< treatment of OA rather than intra-articular injections, with concurrent NSAIDs w/o PPI prophylaxis (risk of PUD)
State the drug class, indication and relevant side effects for pizotifen
- Drug class: Antamine
- Indication: Migraine prophylaxis
- Side effects: Increased appetite, dizziness, drowsiness, dry mouth, fatigue, nausea, weight increase
State the drug class, indication, relevant side effects and STOPP/START criteria for zopiclone
- Drug class: Non-benzodiazepine hypnotic Z-drug
- Indication: Insomnia (short-term use)
- Side effects: Dry mouth, taste bitter, fatigue, fall
- STOPP/START:
- STOP: potentially inappropriate in elderly as can cause protracted daytime sedation or ataxia
State the drug class, indication and relevant side effects for entecapone
- Drug class: COMT (Catechol-O-Methyl Transferase) inhibitor
- Indication: Adjunct to dopamine therapy in PD (because COMT is an enzyme involved in breakdown of dopamine)
- Side effects: Abdominal pain, confusion, constipation, diarrhoea, dizziness, dry mouth, fall fatigue, hallucination, hyperhidrosis, IHD, movement disorders, vomiting
State the drug class, indication and relevant side effects for ropinirole
- Drug class: Dopamine agonist
- Indication:
- PD, either alone or as adjunct to dopamine therapy
- Moderate to severe restless legs syndrome
- Side effects:
- Confusion, dizziness, drowsiness, fatigue, GI discomfort, hallucination, movement disorders, nausea, peripheral oedema, vomiting, vertigo, syncope
- Hypotension- caution in CVD
State the drug class, indication, relevant side effects and interactions, including STOPP/START criteria for Amitryptyline
- Drug class: Tricyclic antidepressant
- Indication:
- Low-dose for neuropathic pain
- Migraine prophylaxis
- Depression
- Abdo pain if pt not responded to laxatives, loperamide, antispasmodics
- Emotional lability in MS
- Side effects:
- (Anticholinergic syndrome)
- Drowsiness, dry mouth, blurred vision, constipation, urinary retention, lengthening of QT interval
- Use low dose for elderly pts- susceptible to psychiatric & cardiac S/E
- Interactions:
- Monoamine oxidase inhibitors- both drug classes increase 5-HT and noradrenaline levels at the synapse and can precipitate htn and hyperthermia or serotonin syndrome
- Can augment antimuscarinic, sedative or hypotensive adverse effects of other drugs
- STOPP/START:
- STOP: dementia, glaucoma, cardiac abnormalities, combination w/ opiate or CCB (severe constipation risk), hx of UR or prostatism (risk of UR)
State the drug class, indication, relevant side effects and interactions for Co-beneldopa/ Co- careldopa
- Drug class: Dopaminergic drugs- Levodopa combined w/ benserazide or carbidopa to prevent peripheral metabolism of levodopa to dopamine
- Indication: Parkinson’s Disease
- Side effects: Dyskinesia, on-off effect, dry mouth, anorexia, palpitations, postural hypotension, psychosis, drowsiness
- Interactions:
- Metoclopramide
- First-generation antipsychotics
- Do not acutely stop
(risk of neuroleptic malignant syndrome and rhabdomyolysis)